Soluble Advanced Glycation End Product (sRAGE) Levels

N/ACompletedNCT06771986

Kayseri City Hospital88 enrolled

Overview

The aim of this study is to evaluate sRAGE levels in children with obesity and to determine the relationship between metabolic status and sRAGE levels in childhood obesity

Study Type

OBSERVATIONAL

Enrollment

Conditions

Obese Patients

Interventions

ObservationOTHER

sRAGE levels were studied in three different groups

Eligibility

Sex: ALLMin age: 10 YearsMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Clinical diagnosis of Obesity BMI over 95th percentile BMI z-score over 2 Exclusion Criteria: Primary hyperlipidemia Primary liver disease Hypothyroidism Diabetes

Locations (1)

Kayseri City Hospital

Kayseri, Turkey (Türkiye)

Outcomes

Primary Outcomes

Evaluation of sRAGE levels in obese and healthy participants

Time frame: From enrollment to the end of at 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.